Loading…
Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats
d, l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate ( d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined...
Saved in:
Published in: | Pharmacology, biochemistry and behavior biochemistry and behavior, 2003-02, Vol.74 (3), p.747-754 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913 |
---|---|
cites | cdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913 |
container_end_page | 754 |
container_issue | 3 |
container_start_page | 747 |
container_title | Pharmacology, biochemistry and behavior |
container_volume | 74 |
creator | Teo, Steve K Stirling, David I Thomas, Steve D Khetani, Vikram D |
description | d,
l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate (
d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of
d,
l-MPH,
d-MPH and
l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg
d,
l-MPH and 1, 10, 50 mg/kg
d-MPH or 1, 100, 500 mg/kg
l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high
d,
l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose
d,
l-MPH and high dose
d- and
l-MPH. Responses in female were significantly different from males in
d,
l- and
l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose
d-MPH and
d,
l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with
d- and
l-MPH compared to equimolar doses of
d,
l-MPH.
l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies. |
doi_str_mv | 10.1016/S0091-3057(02)01073-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18645396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305702010730</els_id><sourcerecordid>18645396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</originalsourceid><addsrcrecordid>eNqFkMtOHDEQRS0EgoHwCUS9ISKLJuVXP1YoQnlJCBZJdpGsGrusMepuD3YPEn8fMzMKy6zqqnSuH4exCw7XHHjz6SdAz2sJur0C8RE4tLKGA7bgXQmat-0hW_xDTthpzo8AoETTHrMTLrSSQvEF-3NPmxSXtMLnEBMOFXlPds5V9FVCS2Ow1bxKFOuR5tXLsF7RFBzOVOHkqlBAt02lOOE0hzhSylWYSnnO79iRxyHT-X6esd9fv_y6_V7fPXz7cfv5rrZKiLnueC9VJxX2klA7KXpUoMoflly6RrVegeAahAVNZYUtLX3fFNATdq7n8ox92J27TvFpQ3k2Y8iWhgEniptseNcoLfumgHoH2hRzTuTNOoUR04vhYF61mq1W8-rMgDBbrQZK7_3-gs1yJPfW2nsswOUewGxx8AknG_IbpzRwwVXhbnYcFR3PgZLJNtBkyYVUtBsXw3-e8hdkLZOB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18645396</pqid></control><display><type>article</type><title>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</title><source>ScienceDirect Journals</source><creator>Teo, Steve K ; Stirling, David I ; Thomas, Steve D ; Khetani, Vikram D</creator><creatorcontrib>Teo, Steve K ; Stirling, David I ; Thomas, Steve D ; Khetani, Vikram D</creatorcontrib><description>d,
l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate (
d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of
d,
l-MPH,
d-MPH and
l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg
d,
l-MPH and 1, 10, 50 mg/kg
d-MPH or 1, 100, 500 mg/kg
l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high
d,
l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose
d,
l-MPH and high dose
d- and
l-MPH. Responses in female were significantly different from males in
d,
l- and
l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose
d-MPH and
d,
l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with
d- and
l-MPH compared to equimolar doses of
d,
l-MPH.
l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(02)01073-0</identifier><identifier>PMID: 12543241</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Biological and medical sciences ; d-Methylphenidate ; Dexmethylphenidate ; Dexmethylphenidate Hydrochloride ; Drug Evaluation, Preclinical - methods ; Female ; Focalin ; Functional observational battery ; l-Methylphenidate ; Male ; Medical sciences ; Methylphenidate ; Methylphenidate - adverse effects ; Methylphenidate - chemistry ; Methylphenidate - pharmacology ; Motor Skills - drug effects ; Motor Skills - physiology ; Neurobehavioral effects ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Ritalin ; Rota-rod ; Stereoisomerism</subject><ispartof>Pharmacology, biochemistry and behavior, 2003-02, Vol.74 (3), p.747-754</ispartof><rights>2002 Elsevier Science Inc.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</citedby><cites>FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14501214$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12543241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teo, Steve K</creatorcontrib><creatorcontrib>Stirling, David I</creatorcontrib><creatorcontrib>Thomas, Steve D</creatorcontrib><creatorcontrib>Khetani, Vikram D</creatorcontrib><title>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>d,
l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate (
d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of
d,
l-MPH,
d-MPH and
l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg
d,
l-MPH and 1, 10, 50 mg/kg
d-MPH or 1, 100, 500 mg/kg
l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high
d,
l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose
d,
l-MPH and high dose
d- and
l-MPH. Responses in female were significantly different from males in
d,
l- and
l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose
d-MPH and
d,
l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with
d- and
l-MPH compared to equimolar doses of
d,
l-MPH.
l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.</description><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Biological and medical sciences</subject><subject>d-Methylphenidate</subject><subject>Dexmethylphenidate</subject><subject>Dexmethylphenidate Hydrochloride</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Female</subject><subject>Focalin</subject><subject>Functional observational battery</subject><subject>l-Methylphenidate</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylphenidate</subject><subject>Methylphenidate - adverse effects</subject><subject>Methylphenidate - chemistry</subject><subject>Methylphenidate - pharmacology</subject><subject>Motor Skills - drug effects</subject><subject>Motor Skills - physiology</subject><subject>Neurobehavioral effects</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Ritalin</subject><subject>Rota-rod</subject><subject>Stereoisomerism</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOHDEQRS0EgoHwCUS9ISKLJuVXP1YoQnlJCBZJdpGsGrusMepuD3YPEn8fMzMKy6zqqnSuH4exCw7XHHjz6SdAz2sJur0C8RE4tLKGA7bgXQmat-0hW_xDTthpzo8AoETTHrMTLrSSQvEF-3NPmxSXtMLnEBMOFXlPds5V9FVCS2Ow1bxKFOuR5tXLsF7RFBzOVOHkqlBAt02lOOE0hzhSylWYSnnO79iRxyHT-X6esd9fv_y6_V7fPXz7cfv5rrZKiLnueC9VJxX2klA7KXpUoMoflly6RrVegeAahAVNZYUtLX3fFNATdq7n8ox92J27TvFpQ3k2Y8iWhgEniptseNcoLfumgHoH2hRzTuTNOoUR04vhYF61mq1W8-rMgDBbrQZK7_3-gs1yJPfW2nsswOUewGxx8AknG_IbpzRwwVXhbnYcFR3PgZLJNtBkyYVUtBsXw3-e8hdkLZOB</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Teo, Steve K</creator><creator>Stirling, David I</creator><creator>Thomas, Steve D</creator><creator>Khetani, Vikram D</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20030201</creationdate><title>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</title><author>Teo, Steve K ; Stirling, David I ; Thomas, Steve D ; Khetani, Vikram D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Biological and medical sciences</topic><topic>d-Methylphenidate</topic><topic>Dexmethylphenidate</topic><topic>Dexmethylphenidate Hydrochloride</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Female</topic><topic>Focalin</topic><topic>Functional observational battery</topic><topic>l-Methylphenidate</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylphenidate</topic><topic>Methylphenidate - adverse effects</topic><topic>Methylphenidate - chemistry</topic><topic>Methylphenidate - pharmacology</topic><topic>Motor Skills - drug effects</topic><topic>Motor Skills - physiology</topic><topic>Neurobehavioral effects</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Ritalin</topic><topic>Rota-rod</topic><topic>Stereoisomerism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teo, Steve K</creatorcontrib><creatorcontrib>Stirling, David I</creatorcontrib><creatorcontrib>Thomas, Steve D</creatorcontrib><creatorcontrib>Khetani, Vikram D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teo, Steve K</au><au>Stirling, David I</au><au>Thomas, Steve D</au><au>Khetani, Vikram D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>74</volume><issue>3</issue><spage>747</spage><epage>754</epage><pages>747-754</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>d,
l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate (
d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of
d,
l-MPH,
d-MPH and
l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg
d,
l-MPH and 1, 10, 50 mg/kg
d-MPH or 1, 100, 500 mg/kg
l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high
d,
l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose
d,
l-MPH and high dose
d- and
l-MPH. Responses in female were significantly different from males in
d,
l- and
l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose
d-MPH and
d,
l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with
d- and
l-MPH compared to equimolar doses of
d,
l-MPH.
l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12543241</pmid><doi>10.1016/S0091-3057(02)01073-0</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-3057 |
ispartof | Pharmacology, biochemistry and behavior, 2003-02, Vol.74 (3), p.747-754 |
issn | 0091-3057 1873-5177 |
language | eng |
recordid | cdi_proquest_miscellaneous_18645396 |
source | ScienceDirect Journals |
subjects | Animals Behavior, Animal - drug effects Behavior, Animal - physiology Biological and medical sciences d-Methylphenidate Dexmethylphenidate Dexmethylphenidate Hydrochloride Drug Evaluation, Preclinical - methods Female Focalin Functional observational battery l-Methylphenidate Male Medical sciences Methylphenidate Methylphenidate - adverse effects Methylphenidate - chemistry Methylphenidate - pharmacology Motor Skills - drug effects Motor Skills - physiology Neurobehavioral effects Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Ritalin Rota-rod Stereoisomerism |
title | Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A00%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurobehavioral%20effects%20of%20racemic%20threo-methylphenidate%20and%20its%20d%20and%20l%20enantiomers%20in%20rats&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Teo,%20Steve%20K&rft.date=2003-02-01&rft.volume=74&rft.issue=3&rft.spage=747&rft.epage=754&rft.pages=747-754&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(02)01073-0&rft_dat=%3Cproquest_cross%3E18645396%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18645396&rft_id=info:pmid/12543241&rfr_iscdi=true |